Digging below the bottom lines of ingredients suppliers and brand behemoths. From the impact of the ongoing economic slowdown to the latest in merger and acquisition activity.
Dairy giant Arla has doubled profits for the first half of its financial year, amid news the two mergers it undertook in 2012 were paying off.
Finnish ag-ingredients-branded foods player Raisio has turned in its best ever quarter and said a focus on emerging markets is driving ongoing sales growth in the sluggish plant stanol, cholesterol...
As Nestlé put a brave face on underwhelming first half results that fell far below market expectations, its Jenny Craig weight management brand was singled out as being one of...
Food firm Kerry Group has posted promising half yearly figures despite UK brands flat-lining in spreads and frozen food as a result of heavy promotions and the horsemeat effect.
Nestlé has cut its sales growth expectations for the full year – but even the revised target will be a stretch, according to the company’s financial chief.
Organic growth and a healthy boost from last year’s €500m Fortitech investment lifted Q2 pre-tax profits 19% to €345m at Dutch ingredients and chemicals giant, Royal DSM.
Soft drinks firm Nichols may be considering a bid for GlaxoSmithKline (GSK) beverage brands Ribena and Lucozade.
€13bn Belgian supplier Solvay has sold its Solactis nutrition division that includes galactofructose (lactulose) to its former nutrition programme manager.
Tate & Lyle CEO Javed Ahmed says earning and profit forecasts are intact – “mid single digit growth” – despite an unseasonably cold spring that has contributed to an annual drop of...
The Alimentary Pharmabiotic Centre (APC) in Cork, Ireland has received a €36m investment from the Irish government that will fund its research activities for at least another six years, its...
UK firm Provexis has filed to demerge the Science in Sport (SiS) consumer sports brand it purchased for €10m in June 2011 from its Fruitflow tomato-based ingredients business, as it...
Swiss nutra and pharma ingredient player Bioseutica has sold 85% of its KD Pharma high-end omega-3 business to German equity firm Capiton. Serious expansion is planned.
Naturex hosted 500 of its employees and guests the weekend just passed as it inaugurated a €12m expansion of its Avignon HQ in southern France. We caught up with CEO...
Strong nutrition sales drove a steady quarter at DSM with sales up 10% in that division, as EBITDA profits improved €5m across the company to €311m compared to €306m in Q1 2012.
Naturex has seen sales rise 13.2% to €83.2m in Q1 2013, with Nutrition its star core business performer, leaping about 33% from €22m to just over €29m.
GlaxoSmithKline will sell its “iconic brands” Lucozade and Ribena to a beverage giant – if the price is right – the company announced in its Q1 results yesterday.
Cosmetics and nutrition are the focal points for a €125m research and development loan gained by supplier Symrise.
Danone reported sales growth in the first quarter of 2013 as demand for baby food in Asia boosted profits, despite continued weakness in Europe.
South Korean regulators have cleared BASF to produce pharmaceutical grade omega-3 at its facility in Scotland.
The European soy sector says a UN report that found dairy proteins offer a superior amino acid profile to plant proteins is only meaningful for the malnourished.
Costs relating to the establishment of the a2 Milk UK joint venture contributed to a H1 profits decrease for Australasian dairy processor A2 Corporation (A2C), the company has revealed.
Food supplement markets in Poland, the Czech Republic, Romania, Hungary, Bulgaria and Slovakia have pushed through the €1bn mark for the first time, with Romania starring with 24% growth in...
Finnish ag-food giant Raisio has sold its €7m a year oat, soy and rice foods business that includes its Soygurt business to €330m Norwegian food company Kavli.
Nestlé has bought its second brain health-focused medical foods start-up in eight months after snaffling Red River Pharma-owned Pamlab which makes high-dose vitamin supplements targeting depression, diabetes and Alzheimer’s.
2012 sales have risen 1.5% at Forté Pharma, the food supplements arm of Spanish player Natraceutical, with weight management products dominating.